1. Immunosuppressive Preconditioning or Induction Regimens

   • Henkie P. Tan
   • Marc C. Smaldone
   • Ron Shapiro

   Leading Article 12 September 2012 Pages: 1535 - 1545

   

2. Pathophysiology, Clinical Presentation and Treatment of Gout

   • Gim Gee Teng
   • Raj Nair
   • Kenneth G. Saag

   Therapy In Practice 12 September 2012 Pages: 1547 - 1563

   

3. Recent Developments in the Treatment of Otitis Media with Effusion

   • Ellen M. Mandel
   • Margaretha L. Casselbrant

   Therapy In Practice 12 September 2012 Pages: 1565 - 1576

4. Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

   • Chantal Bernard-Marty
   • Fabienne Lebrun
   • Martine J. Piccart

   Review Article 12 September 2012 Pages: 1577 - 1591

   

5. Intravenous Ibandronate

   • Katherine F. Croom
   • Lesley J. Scott

   Adis Drug Profile 12 September 2012 Pages: 1593 - 1601

   

6. Intravenous Ibandronate in the Treatment of Osteoporosis

   • Jean-Yves Reginster

   Adis Drug Profile 12 September 2012 Pages: 1602 - 1602

7. Intravenous Ibandronate in the Treatment of Osteoporosis

   • Juliet Compston

   Adis Drug Profile 12 September 2012 Pages: 1602 - 1602

8. Intravenous Ibandronate in the Treatment of Osteoporosis

   • Silvano Adami

   Adis Drug Profile 12 September 2012 Pages: 1602 - 1603

9. Entecavir

   • Dean M. Robinson
   • Lesley J. Scott
   • Greg L. Plosker

   Adis Drug Evaluation 12 September 2012 Pages: 1605 - 1622

   

10. Entecavir

    • Robert G. Gish

    Adis Drug Evaluations 12 September 2012 Pages: 1623 - 1623

11. Entecavir

    • Ching-Lung Lai
    • Man-Fung Yuen

    Adis Drug Evaluations 12 September 2012 Pages: 1623 - 1624

12. Orlistat

    • Sheridan Henness
    • Caroline M. Perry

    Adis Drug Evaluation 12 September 2012 Pages: 1625 - 1656